Skip to main content
PLOS One logoLink to PLOS One
. 2023 Apr 13;18(4):e0280711. doi: 10.1371/journal.pone.0280711

Tailoring baker’s yeast Saccharomyces cerevisiae for functional testing of channelrhodopsin

Sebastian Höler 1, Daniel Degreif 1, Florentine Stix 1, Shang Yang 2, Shiqiang Gao 2, Georg Nagel 2, Anna Moroni 3, Gerhard Thiel 1,4, Adam Bertl 1,4, Oliver Rauh 1,4,*
Editor: Patrick Lajoie5
PMCID: PMC10101416  PMID: 37053213

Abstract

Channelrhodopsin 2 (ChR2) and its variants are the most frequent tools for remote manipulation of electrical properties in cells via light. Ongoing attempts try to enlarge their functional spectrum with respect to ion selectivity, light sensitivity and protein trafficking by mutations, protein engineering and environmental mining of ChR2 variants. A shortcoming in the required functional testing of large numbers of ChR2 variants is the lack of an easy screening system. Baker’s yeast, which was successfully employed for testing ion channels from eukaryotes has not yet been used for screening of ChR2s, because they neither produce the retinal chromophore nor its precursor carotenoids. We found that addition of retinal to the external medium was not sufficient for detecting robust ChR activity in yeast in simple growth assays. This obstacle was overcome by metabolic engineering of a yeast strain, which constitutively produces retinal. In proof of concept experiments we functionally express different ChR variants in these cells and monitor their blue light induced activity in simple growth assays. We find that light activation of ChR augments an influx of Na+ with a consequent inhibition of cell growth. In a K+ uptake deficient yeast strain, growth can be rescued in selective medium by the blue light induced K+ conductance of ChR. This yeast strain can now be used as chassis for screening of new functional ChR variants and mutant libraries in simple yeast growth assays under defined selective conditions.

Introduction

In one approach of optogenetics natural or synthetic light gated ion channels are expressed in cells of interest, where they can be activated or inhibited by wavelength-specific light stimuli [1, 2]. This offers the possibility of non-invasive modulation of activity in the targeted channels with high temporal and spatial precision. By using this remote control over channel activity, the electrical properties of cells can be precisely tuned in experimental research and even for biomedical applications [38].

The first and so far most frequently used tools in this type of optogenetics are channelrhodopsins [911]. The originally discovered channelrhodopsins 1 and 2 (ChR1 and ChR2) from the green alga Chlamydomonas rheinhardtii and their currently known variants have structural similarities to microbial ion pump rhodopsins, but unlike the latter, ChRs act directly as light-activatable cation channels [9, 10]. The original ChR2 absorbs blue light with a maximum at 460 nm via an all-trans retinal chromophore in complex with the channel protein. Upon light absorption the chromophore undergoes a trans to cis isomerization, which eventually leads to channel opening. The open channel is cation-selective and transports monovalent (H+, Na+, K+, etc.) and divalent (e.g. Ca2+) ions [10, 12].

Increasing sophistication of optogenetic applications poses a growing demand for light gated channels with different functional properties. This includes different types of ion selectivity, shifts of action spectra [13, 14] as well as an elevated sensitivity to light [15]. Also channels with different kinetic properties for long timescale experiments or high precision optogenetic control [16] or proteins with improved sorting to the target membrane are required [17]. Intensive work on ChRs over the last two decades has shown that many of the desired features like anion selectivity or increased K+ selectivity can already be found in some exotic natural occurring variants of this protein [18, 19]. Alternatively, they can be achieved by rational design and mutagenesis of existing ChRs [20, 21]. Altogether these findings suggest that ChRs have a high degree of plasticity with respect to structure/function correlates. Hence it is reasonable to speculate that still more functional features can be achieved via protein engineering [22] or environmental mining [22, 23]. The electrophysiological characterization of ChRs variants and mutants in oocytes or mammalian cells is this context still the gold standard. But while this works well for small numbers of candidate proteins a screening of large numbers of mutants or variants would benefit from a simple high throughput screening system. This would provide a fast way of identifying candidate proteins with new and interesting functional features worth pursuing in a more detailed analysis. For many ion channels from eukaryotic cells such a simple screening system is offered by baker’s yeast Saccharomyces cerevisiae [24]. This unicellular eukaryotic organism proved in the last two decades an optimal platform for a rapid testing of channel activity in newly discovered channel proteins [25], functional screening of channel mutants [26] and testing of ion selectivity as well as drug sensitivity [27, 28]. The same system was also useful for a rapid screening of efficient sorting of channel proteins to the plasma membrane [29] as well as for functional testing of de novo engineered channel proteins [30]. ChRs have so far already been expressed in yeasts like Komagatella phaffii (aka Pichia pastoris) and S. cerevisiae for producing large amounts of proteins [31, 32]. But to our knowledge, there is only one publication reporting expression and functional studies of ChR2 in S. cerevisae. ChR2-mediated currents were in this study monitored in patch-clamp recordings from giant yeast protoplasts produced by electrofusion [33]. Apart from this study, which seems in terms of the experimental approach much too complex for employing it in functional screening experiments, there are no reports yet on a functional testing of ChRs in yeast in general or in S. cerevisiae in particular. One obstacle for using ChRs in S. cerevisiae is that the yeast is neither producing the chromophore all-trans retinal nor carotenoids as a precursor. This limitation can be overcome in some cases like in Xenopus oocytes by adding the membrane permeant retinal to the extracellular solution [34] or in plants by introducing retinal-producing genes [35]. Studies on functional reconstitution of opsins in S. cerevisiae however have shown that only a small fraction of the total expressed recombinant opsin exhibited an integration of the chromophore into the protein [36]. Hence it is not clear if an extracellular supply of the chromophore is sufficient for generating functional ChRs in S. cerevisiae.

Here, we show that application of retinal into the external medium was not sufficient for guaranteeing ChR activity sufficient to trigger growth phenotypes in baker’s yeast. By different steps of metabolic engineering, we were however able to generate a yeast strain, which constitutively produces the retinal chromophore, which is essential for ChR activity. This yeast strain can be used as a chassis to successfully express ChRs and test their light stimulated function in simple yeast growth assays.

Results and discussion

In order to generate a detectable phenotype in yeast growth the light-activated Channelrhodopsin 2 (ChR2) must be localized in the plasma membrane. To test synthesis and sorting of ChR2 in yeast, an eYFP-tagged version of the protein was expressed under control of an inducible GAL1 promotor. Confocal images from an overnight culture show that ChR2 is synthesized in yeast in appreciable amounts. The fluorescent signal is visible in endo- membranes, presumably the endoplasmic reticulum, as well as in the plasma membrane (Fig 1A). Since yeast cells require only a low concentration of channels in their plasma membrane for ion uptake, a detectable GFP signal from ChR2 in the plasma membrane should hence allow functional testing of the light gated channel in yeast growth assays. Indeed, control experiments (S1 Fig) confirm that a low fluorescent signal form a channel protein in the plasma membrane of yeast cells is sufficient for employing them in complementation assays. The sensitivity of these complementation assays to membrane impermeable blockers (e.g. [27]) underpins that the complementation assays are determined by the plasma membrane resident protein and not by protein in endo-membranes.

Fig 1. ChR2 is properly expressed in yeast strain BY4741 but shows no sign of function.

Fig 1

(A) Confocal images of BY4741 yeast strain in SGal-ura overnight cultures. Transmission images (left) and corresponding fluorescent images (right) of eYFP-tagged ChR2. Inset: Magnification and overlay of transmission and fluorescent images from cell indicated in right panel showing that fluorescence is visible in position of the plasma membrane. (B) Droplet test of BY4741 transformed with the pGREG576 plasmid bearing the ORF for the capsaicin receptor TRPV1 from Rattus norvegicus. In SD-ura, without induction of transcription, the presence of either the channel activator capsaicin, the permeant Na+ or both had very little effect on growth (left panel). With induction of transcription by galactose (right panel), channel activation by capsaicin alone had little effect on growth. However, the additional presence of 500 mM NaCl resulted in a strong growth inhibition. (C) Luminometric assay reveals capsaicin triggered calcium influx in BY4741 yeast cells expressing TRPV1, but not in control cells harbouring the empty pGREG576 plasmid. Arrow indicates injection of 10 μM capsaicin. Curves are the means of 6 recordings for the TRPV1 strain and 2 recordings for the empty vector control. (D). Droplet test of BY4741 transformants without (-) and with (+) 500 mM NaCl salt stress. Cells grown in absence (-) and presence (+) of 10 μM retinal for three days in dark and light. Cells harboring the empty pGREG506 plasmid (ev) and cells expressing either ChR2 (ChR2) or its D156C mutant (D156C) where spotted as serial dilutions from an OD600 = 1 on SGal-ura agar plates at 10 μL per spot.

A simple test could be based on a light induced inhibition of yeast growth by Na+. Even though elevated concentrations of Na+ in the cytosol are toxic, wild type yeast cells generally tolerate high sodium concentrations of >1M in the external medium [37]. This tolerance should be decreased when cells express a protein, which elevates the otherwise low Na+ conductance of the plasma membrane. To test this prediction, we expressed the Na+ permeable capsaicin receptor TRPV1 in yeast. The growth assay in Fig 1B confirms that activation of this Na+ conducting channel by capsaicin causes a strong inhibition of yeast growth in a medium with a high Na+ concentration. Function of TRPV1 and plasma membrane localization in this yeast strain was also confirmed by capsaicin triggered calcium increase monitored in a aequorin based luminometric assay (Fig 1C). This capsaicin induced calcium signal was absent in the yeast strain not expressing TRPV1. We hypothesized that activation of the Na+ conducting ChR2 by light should render the growth of yeast expressing this protein in the same manner sensitive to high extracellular Na+.

To test the function of the light gated channel in such a simple growth assay, yeast cells transformed with ChR2 or its D156C mutant, which shows increased open probability in the light [38], were grown on selective agar plates (SGal-ura) ± 500 mM NaCl (Fig 1D). In the absence of 500 mM Na+, BY4741 cells transformed with the empty plasmid (ev) showed equally robust growth in the dark and in the light, and no difference was observed for cells expressing ChR2 or its D156C mutant. The presence of 500 mM NaCl in the agar caused a slight growth inhibition in all three yeast strains, which is most evident by comparing colonies at the 1000-fold dilution (Fig 1D); but as in the absence of Na+, there was no light effect detectable. Since yeast cells neither produce carotenoids as precursor nor retinal as essential chromophore for ChR2 function, agar plates containing 500 mM Na+ were additionally supplemented with 10 μM retinal, to allow the yeast cells to take up the chromophore and incorporate it into ChR2. In contrast to our expectation, yeast grown for three days in SGal-ura + 500 mM Na+ showed no light sensitivity, regardless of the presence or the absence of retinal. The data in Fig 1D hence underscore a general weak sensitivity of the cells to 500 mM NaCl stress, but this stress is not augmented by conditions which should promote ChR2 or ChR2(D156C) activity in the plasma membrane. Therefore, we concluded that the conductance of ChR2 and its D156C mutant was too small or not sufficiently activated under the experimental conditions tested.

One possible explanation for this negative result is that retinal might not be sufficiently taken up for rendering ChR2 light sensitive. During incubation of cells in the light with externally supplied retinal at a rather high concentration, we observed a decrease in the intensity of the yellow color of the agar medium. To test if this can be interpreted as evidence for an uptake of retinal into the cells, experiments from Fig 1B were repeated without cells. The images in Fig 2A show agar plates with 1 mM retinal before and after incubation for 24 h in either darkness or light. The representative images and the corresponding analysis of the yellow color values (Fig 2A and 2B) exhibit a visible bleaching only after light exposure. Hence a decrease in color intensity is not evidence for retinal uptake into cells but rather an indication for a light-dependent photo-destruction of the chromophore.

Fig 2. Illumination bleaches retinal in medium.

Fig 2

(A) Agar plates containing 1 mM retinal directly after preparation (left, ctrl) and 24 h after keeping plate in the dark (center, 24 h dark) or in the light (right, 24h light, right). Illumination bleaches retinal-containing agar. (B) Yellow color of agar plate above background was obtained from deconvolution of images and plotted as relative value of plates after 24 h incubation in light or dark relative to pre-incubation (ctrl). Mean ± SD of independent replicates.

Engineering of an all-trans retinal producing trk1Δtrk2Δ yeast strain

For engineering a versatile yeast chassis strain for screening ChR function, we decided to use the PLY240 strain [37], which is devoid of the major K+ uptake systems Trk1p and Trk2p and thus suitable for studying complementation of K+ uptake deficiency by heterologous K+ transporters. In addition, the absence of Trk1p and Trk2p offers the benefit of an increased sensitivity towards toxic external cations such as Na+, Li+ or Cs+ [37, 39]. To overcome the absence of retinal in yeast, we modified the PLY240 strain for constitutive synthesis of this essential cofactor for ChR. In an initial step three genes (crtI, crtYB and crtE) from the carotenoid-producing yeast Xanthophyllomyces dendrorhous, which enable β-carotene synthesis in S. cerevisiae cells [40], were genomically integrated in a marker-free manner. For this, a polycistronic construct [41] was integrated into the CAN1 locus of the PLY240 (trk1Δtrk2Δ) yeast strain [37] by means of the CRISPR/Cas9 technology [42] resulting in strain SHY1. Integration of these genes generated yellow-colored yeast colonies, indicating successful production of β-carotene in the engineered cells (Fig 3A, left agar plate). In the next step a carotene monoxygenase (carX) from the ascomycete Fusarium fujikuroi [43] was genomically integrated into the kanMX cassette (remaining from the trk2-deletion in PLY240) of the SHY1 strain to give strain SHY2. This resulted in a weaker yellow color of the colonies (Fig 3A, right agar plate) suggesting cleavage of β-carotene to retinal by the carX activity.

Fig 3. Engineering of retinal producing yeast.

Fig 3

(A) PLY240 cells with genomic integration of the polycistronic construct for β-carotene production without (left) and with the carotenoid monooxygenase carX (right) were plated at 1:104 dilution on nonselective medium containing a high K+ concentration to yield single colonies. (B) trk1Δtrk2Δ cells with genomic integration of the polycistronic construct for β-carotene production and a second crtI gene without (left) and with (right) the carotenoid monooxygenase carX plated as in A. The colonies highlighted by frames are magnified and shown in the center. Images in A and B were taken after 4 days of incubation. Scale bar = 10 mm. (C) UPLC analysis of retinal production in yeast. Ethanol extract from trk1Δtrk2Δ yeast cells as in B with the genomically integrated polycistronic β-carotene pathway, a second crtI gene and carX was used for UPLC analysis with 5 μM all-trans retinal as reference. Data were normalized to the largest peak in the chromatograms. The analysis shows the same elution behavior of the extract as for the reference with a signal at 3.54 min indicating production of all-trans retinal in yeast cells.

However, UPLC analysis of organic phase extracts from these cells did not detect all-trans retinal suggesting that the β-carotene synthesis is insufficient to form enough precursors for robust all-trans retinal synthesis. Therefore, a second crtI gene was integrated into the YPRCΔ15 locus [44] of the aforementioned β-carotene producing cells (SHY1) to give strain SHY3. We reasoned that this might increase biosynthesis of β-carotene [40]. Indeed, after genomic integration of the polycistronic β-carotene synthesis pathway plus a second crtI gene the SHY3 colonies showed a more intense orange color (Fig 3B, left agar plate) indicating enhanced carotenoid production.

Following genomic integration of carX into the kanMX cassette of the SHY3 cells, the colonies of the resulting SHY4 strain lost their intense orange color implying efficient β-carotene cleavage and synthesis of retinal. (Fig 3B, right agar plate). This was confirmed by UPLC analysis of an ethanol cell extract, which shows the same elution peak as a 5 μM all-trans retinal reference sample (Fig 3C).

We reasoned that a ChR variant with higher conductance for Na+ and K+ might generate a stronger phenotype than wild type ChR2. Thus, a ChR variant, named ChR2-5x, with improved Na+ and K+ conductance (Fig 4A, [45]) was selected to perform further studies.

Fig 4. Engineering of N/K-ChR2.

Fig 4

(A) Schemes of ChR2-5x and N/K-ChR2. ChR2-5x is a ChR2 variant with 5 point mutations. N/K-ChR2 comprises ChR2-5x scaffold with CR10 (= first 10 amino acids from proton pump rhodopsin CsR) and N17 (= first 17 amino acids from ChR2). The construct contains additional domains in N- and C-terminus namely LR domain (= N-terminal signal peptide Lucy-Rho), T domain (= the plasma membrane trafficking signal from Kir2.1) and E domain (= the endoplasmic reticulum (ER) export signal from Kir2.1). (B) Shift in reversal potential (ΔVr) recorded in Xenopus ooccytes expressing either ChR2-5x or ChR2-XXM upon changing extracellular solution from 1 mM to 120 mM NaCl (ΔVr Na+) or KCl (ΔVr K+). Values represent mean ± SD, n = 3–4. (C) Images of Xenopus oocytes expressing ChR2-5X and N/K-ChR2; scale bar = 1 mm. (D) Representative photocurrent trace from N/K-ChR2 expressing oocyte elicited by illumination with blue light (472 nm, blue bar); oocyte incubated in solution containing (in mM) 110 NaCl, 5 KCl, 2 BaCl2, 1 MgCl2, 5 HEPES/ pH 7.6). Holding potential at -70 mV. (E) Mean photocurrent amplitudes of ChR2-5x and N/K-ChR2 recorded as in C; n = 13–15. P value of statistical significance in B and E from unpaired t-test indicated as *** = P < 0.001.

When ChR2-5x was expressed in Xenopus oocytes and activated by blue light an elevation of extracellular Na+ or K+ from 1 mM to 120 mM generated a positive shift of the reversal potential by 91.5 mV in NaCl and 81 mV in KCl containing solution (Fig 4B). The amplitude of the shift is higher in the case of ChR2-5x than with the ChR2-XXM variant [46] (Fig 4B). The same is true for experiments with wt-ChR2, which exhibits in the same assay only a moderate positive shift of 24 mV in Na+ and 21 mV in K+ [47]. The results of these experiments indicate an enhanced selectivity of the channel for K+ and Na+ over other competing cations. Additional modifications of the N- and C-termini of ChR2-5x, resulting in the variant N/K-ChR2 (Fig 4A), further increased the expression level and/or membrane trafficking of ChR2-5x (Fig 4C). This is apparent in a higher GFP fluorescence in oocytes (Fig 4C) and reflected in a significantly higher photocurrent amplitude of N/K-ChR2 compared to ChR2-5x (Fig 4E). When the optimized ChR2-5x, termed N/K-ChR2, was expressed in SHY4 cells, we found that the fluorescent signal of the GFP tag was, like in Fig 1, visible in some endo-membranes but also as ring at the periphery of cells (Fig 5A); in many cells the fluorescence was seen, like in the example indicated by an arrow in Fig 5A, only in the cell periphery. To estimate the distribution of fluorescence in the cell periphery relative to the cell interior we measured in 30 randomly chosen cells the ratio of mean fluorescence from the entire cell image with (Fcell) and without (Fcyt) the peripheral ring. The value of this ratio Fcell/Fcyt is 1.8 ±0.7, confirming that the peripheral ring shows on average a much higher fluorescence signal than the inner part of the cells. Since the tonoplast in yeast cells is well separated from the plasma membrane, the intense fluorescence of the peripheral ring underpins an efficient sorting of the protein to the plasma membrane.

Fig 5. Expression and functional characterization of N/K-ChR2 in SHY4 cells.

Fig 5

(A) Fluorescence (left) and transmission light (center) images of SHY4 cells constitutively expressing N/K-ChR2-eYFP. Overlay (right) confirms localization of fluorescent tagged channel (in blue) with endo-membranes and the plasma membrane. The cell indicated by arrow exhibits fluorescence nearly exclusively in plasma membrane. Scale bar = 5 μm. (B) Growth of SHY4 cells transfected either with empty vector (open symbols) or channelrhodopsin-2 variant (N/K-ChR2, closed symbols) in SD-ura + 10 mM K+ medium with 0 (black) or 400 mM NaCl (blue). Growth measured in 30 sec intervals as change in OD500. While the presence of N/K-ChR2 has little impact on growth in absence of NaCl it reduces growth in the presence of salt stress. Inset: data in 400 mM NaCl replotted for cells ± N/K-ChR2. After ≥12 h cells without N/K-ChR2 grow (P<0.01) significantly more than controls. (C) Maximum growth rate (μmax) from data in B for cells with empty vector (open bars) and with N/K-ChR2 (filled bars) in medium with 0 or 400 mM NaCl. Data are mean ± SD of 3 independent experiments. P values were calculated by student t-test.

After engineering yeast cells which constitutively produce all-trans retinal, we reasoned that ChR2 should be functional in these cells. Given that the light-activated channel is conducting Na+, we repeated Na+ mediated growth inhibition experiments. For that, cells were grown in liquid medium for 48 h in 24 well plates and the optical density at 500 nm (OD500) was continuously monitored in a plate reader; one OD500 unit is here equivalent to 2.3 x 10−7 cells/ml. The blue-green light from a 20 W tungsten halogen light source served here both as a stimulus for activating ChR2 and as a light source for measuring the OD500. Control cells and cells transformed with ChR2 were incubated in SD-ura medium, supplemented with 10 mM KCl plus different concentrations of NaCl (0, 400, 500 or 600 mM NaCl). It should be noted that standard synthetic defined media (SD media) comprise an intrinsic K+ content (from Yeast Nitrogen Base, YNB) of 7 mM. A total concentration of 17 mM K+, as in SD-ura + 10 mM K+, is just sufficient to allow slow growth of these K+ uptake deficient cells (trk1Δtrk2Δ-background). We expected that these conditions with limiting K+ supply in the trk1Δtrk2Δ-background, resulting in low growth, might be more susceptible to Na+ stress, which has already been observed elsewhere [37].

Growth of the SHY4 yeast strain transformed with N/K-ChR2 was measured in a plate reader in 30 s intervals over time by illuminating cells with 500 nm light. The resulting growth curve shows that cells grow under these conditions in the absence of Na+ (Fig 5B). The growth rates are similar irrespective of whether cells were transformed with the empty vector or N/K-ChR2. Control cells with empty vector start growing in the presence of 400 mM NaCl with a delayed and reduced growth rate (Fig 5B and 5C). Cells expressing N/K-ChR2 exhibit an even longer delay and a significantly reduced maximal growth rate (Fig 5B and 5C). The same results were obtained in experiments with higher Na+ concentrations (500 mM and 600 mM); in all cases the presence of Na+ in the medium caused a reduced maximal growth rate and this effect was strongly augmented in cells transformed with N/K-ChR2 (Fig 5C). This is consistent with a scenario in which N/K-ChR2 is active in the all-trans retinal producing cells. Its activation by light elevates the conductance of the plasma membrane for Na+ and the resulting entry of Na+ into the cells is exerting a negative effect on yeast growth. Hence already with this simple growth assay it is possible to test the function of N/K-ChR2 in yeast; after ca. 12h of incubation it is already possible to detect the functional effect of N/K-ChR2 compared to control cells (Fig 5B). In future experiments this system can be further improved by deleting additional genes such as ENA1-5 [48], NHA1 [49] and NHX1 [50], which encode for the main transporters for Na+ export from the cytosol in yeast. This additional modification will make the test system even more sensitive and presumably abolish growth in the presence of high Na+ concentrations.

K+ complementation

In the next assay we tested whether N/K-ChR2 can accomplish light-dependent K+ mediated complementation of growth in the potassium uptake deficient SHY4 cells. Cells transformed with N/K-ChR2 were therefore grown on agar plates with medium containing high or low K+; the latter condition serves as a selection medium. 10-fold serial dilutions of a cell suspension with OD600 = 1.0 were spotted onto SD-ura agar plates supplemented with high K+ (100 mM) or without K+ supplementation. Plates were then incubated under constant blue light illumination (450 nm, 40 μW/mm2) or in the dark. Inspection of cells 72 h after incubation shows that they were growing in high K+ concentration irrespectively on whether they were kept in light or dark. In contrast cells failed to grow on medium with a low K+ concentration independent on whether they were illuminated by blue light or not (S2 Fig). Different from our expectations, these data imply that an activation of N/K-ChR2 by light does not provide a K+ conductance, which is able to rescue growth of the K+ uptake deficient yeast in low K+.

One reason for this negative result could be that the rescue effect of N/K-ChR2 is only modest and not visible in the growth assay on agar. We therefore tested whether we could detect rescue of growth in liquid culture assays as in Fig 5. Growth of SHY4 cells, transformed with either empty vector (ev) or N/K-ChR2 suspended in SDAP-ura medium supplemented with additional 0.1, 1, 10 or 100 mM KCl were monitored as in Fig 5B in a plate reader. They were therefore illuminated with 500 nm light which served for activating N/K-ChR2 and for measuring changes in OD of the cells. In this condition over 48h, cells grew only in medium with ≥10 mM KCl, but without difference between presence/absence of N/K-ChR2 (Fig 6A). The results of these experiments indicate that the plate reader light is sufficient for activating sufficient N/K-ChR2 channels for eliciting a toxic Na+ influx (compare Fig 4B) but not for providing enough K+ influx for growth.

Fig 6. N/K-ChR2 rescues K+ mediated growth of yeast mutant only in high blue light.

Fig 6

(A) Growth of SHY4 cells transformed with either empty vector (ev, open symbols)) or N/K-ChR2 (closed symbols) in SDAP medium with 0.1 (black), 1 (blue), 10 (green) or 100 (red) mM KCl. Growth was monitored as in Fig 5B. When cells were illuminated by 500 nm light from the plate-reader, they grew over a period of 48h only in medium with ≥10 mM KCl but without appreciable difference between presence/absence of N/K-ChR2. Data are mean ± SD of 3 independent experiments. (B) Relative growth of SHY4 cells expressing N/K-ChR2 in dark (black bar) or illuminated with 40 μW/mm2 of light (465 nm: blue bar) in SD-ura medium ± 400 mM NaCl on a background of low (7 mM) or medium high (17 mM) KCl. Growth expressed as OD value (rel. OD600) of N/K-ChR2 expressing cell (grey bar) relative to the respective control with empty vector (open bars). Growth is substantially reduced by NaCl only in cells expressing N/K-ChR2 upon light exposure. (C) Growth is increased in blue light grown cells expressing N/K-ChR2 only in low K+ medium e.g. when K+ influx is the limiting growth factor, but not in medium high K+ (17 mM). (D) In low K+ (7 mM), growth of cells expressing N/K-ChR2 is increased in cells exposed to blue light (blue bar), but not in cells exposed to red light (650 nm, red bar) or kept in the dark (black bar). Data in (B) and (C) represent growth after 48 h, data in (D) represent growth after 24 h. All data are mean ± SD of ≥3 independent experiments. P value of statistical significance from t-test indicated as * = P<0.05, ** = P<0.01 and *** = P<0.001.

In the next step cells were therefore incubated in wells of a growth plate loaded with SD-ura medium with no (0 mM) or a high (400 mM) concentration of NaCl on a background of a low (7 mM) or medium high (17 mM) KCl concentration. Control cells with empty vector and cells transformed with N/K-ChR2 were continuously illuminated with 465 nm at 40 μW/mm2 or kept in the dark. Growth of N/K-ChR2 expressing cells was measured after 48 h as an increase in OD600 relative to growth of empty vector controls. The data in Fig 6B show that cells transformed with N/K-ChR2 grow in the dark with and without NaCl in the medium like the respective empty vector controls. In medium with high NaCl, growth in blue light is inhibited by ≥35% in the N/K-ChR2 transformed cells irrespective of the KCl concentration (Fig 6B). The results of these experiments are in good agreement with data in Fig 5B and 5C in that activation of N/K-ChR2 promotes Na+ influx, which in turn inhibits cell growth.

Interesting to note is that only cells transformed with N/K-ChR2 and exposed to blue light experience in a selective medium with low (7 mM) KCl and no NaCl a significant stimulation of growth (Fig 6C, middle bars). Here, the final OD600 after 48 h is 65% higher than the respective empty vector controls. This finding is consistent with the idea that activation of N/K-ChR2 generates a conductance for K+, which can rescue the deficient endogenous K+ uptake systems in low K+ medium. To further test this assumption the same experiments were repeated in medium with an elevated K+ concentration (17 mM) e.g. a concentration, which is no longer suppressing growth of the yeast mutant. In this scenario the external K+ concentration and therefore K+ influx is already high enough to allow growth of the trk1Δtrk2Δ-strain, therefore additional activation of the ChR2 mediated K+ conductance has only little further positive effect on growth (Fig 6C, right bars).

The light dependency of N/K-ChR2 predicts that growth rescue in a selective low K+ medium should be effective in blue but not in red light. To test this prediction, experiments were repeated with either red light or blue light. To address the question whether the stimulating effect of blue light under these conditions is already viable at a shorter incubation time, cell growth was monitored 24h after inoculation. The data in Fig 6D show again no large difference in growth between cells with or without N/K-ChR2 in the dark but a strong growth stimulation in blue light. This underpins that a positive effect of blue light can already be detected after 24h of incubation. In the same assay red light has no perceivable impact on cell growth (Fig 6D). Collectively also these data agree with a scenario in which N/K-ChR2 is active in blue light in the engineered yeast cells and that simple growth assays can be used to test for channel activity.

Conclusion

The yeast Saccharomyces cerevisiae offers many experimental benefits for a fast and easy screening of ion channel proteins [2430]. Despite of this experimental advantages S. cerevisiae has so far not yet been employed for engineering or modifying rhodopsin-based optogenetic tools because yeast neither synthesizes the essential cofactor retinal nor its carotenoid precursor. To overcome this obstacle, we have successfully engineered and optimized a yeast strain, which contains the full metabolic pathway for the synthesis of retinal. The data show that retinal endogenously generated by these yeast cells is sufficient to guarantee robust light dependent activity of ChR2 in S. cerevisiae. In proof of concept experiments we confirm that the weak cation selective conductance of this channel [10], rescues in the retinal producing strain, growth of a K+ uptake-deficient yeast mutant or inhibits growth by high extracellular Na+ in a light dependent manner. Collectively, the simple experiments already show that the retinal producing yeasts can be used as a reliable and cheap test system for screening basic ChR2 functions. Given the simplicity of the system and the robust nature of optical density as a read-out signal, the system can be easily scaled up in future for high-throughput screening including robotics platforms. Promising candidate proteins, which emerge from this screening of large libraries, can in the next step be characterized in depth with conventional electrophysiological assays. A combination of the present screening systems with a bias for K+ uptake to promote growth and a bias against Na+ influx to prevent growth inhibition is only one example for an experimental strategy to screen for mutant ChR2 channels with increased K+ over Na+ selectivity. By combining the benefits of genetic modifications in yeast with the wealth of yeast mutants with defined functional phenotypes it will be possible to create a versatile platform for engineering ChR2 and related retinal dependent proteins like baceriorhodopsins with new channel functions.

Materials and methods

Generation of plasmids

For all cloning steps the NEBuilder HiFi DNA Assembly Master Mix (NEB GmbH, Frankfurt, Germany) was used. Generated plasmids in Table 1 were amplified in E. coli DH5α and sequence verified by Sanger sequencing (Microsynth Seqlab GmbH, Göttingen, Germany).

Table 1. Plasmids used in this study.

name properties reference
pGREG506 empty vector with GAL1 promoter in front of HIS3 stuffer [51]
pGREG506-PTEF1 pGREG506 with inducible GAL1 promoter replaced by constitutive TEF1 promoter [52]
pGREG506-ChR2 pGREG506 with HIS3 stuffer replaced by ChR2 This study
pGREG506-D156C pGREG506 with HIS3 stuffer replaced by D156C mutant of ChR2 This study
pGREG506-ChR2-eYFP pGREG506 with HIS3 stuffer replaced by C-terminal eYFP-tagged ChR2 This study
pGREG506-PTEF1-ChR2-eYFP pGREG506-PTEF1 with HIS3 stuffer replaced by C-terminal eYFP-tagged ChR2 This study
pGREG506-N/K-ChR2-eYFP pGREG506 with HIS3 stuffer replaced by C-terminal eYFP-tagged N/K-ChR2 This study
pGREG506-PTEF1-N/K-ChR2-eYFP pGREG506-PTEF1 with HIS3 stuffer replaced by C-terminal eYFP-tagged N/K-ChR2 This study
pGREG576 empty vector with GAL1 promoter in front of HIS3 stuffer for expression of N-terminal GFP fusion proteins [51]
pGREG576-TRPV1 pGREG576 with HIS3 stuffer replaced by TRPV1, expression of N-terminal TRPV1-GFP fusion protein under control of GAL1 This study
pEVP11-AEQ 2μ-plasmid containing LEU2 marker and the gene for constitutive expression of apoaequorin under control of the ADH-promoter [53]
pCAS9c all-in-one CRISPR/Cas9 plasmid with gRNA expression cassette containing protospacer stuffer [42]
pCAS9c-CAN1 pCAS9c with: gRNA expression cassette containing sprotospacer sequence for CAN1 This study
pCAS9c-kanr pCAS9c with: gRNA expression cassette containing protospacer sequence for kanr This study
pCAS9c-YPRCΔ15 pCAS9c with: gRNA expression cassette containing protospacer sequence for YPRCΔ15 This study
pUDC082 template for PCR amplification of PGAP-crtYB-T2A-crtI-T2A-crtE-TTEF1 [41]
pGEX-carX template for PCR amplification of carX [43]
YIplac211-YB/I/E template for PCR amplification of crtI [40]
pcDNA3.1-TRPV1 Template for PCR amplification of TRPV1 [54]

The table specifies the names and essential properties of the plasmids used in this study.

Plasmid pGREG506-PTEF1-ChR2-eYFP was generated by cloning PCR amplified ChR2-eYFP (P19/P20) using pGEM-HE-ChR2-eYFP [10] as template in SalI restricted pGREG506-PTEF1. Plasmid pGREG506-PTEF1-N/K-ChR2-eYFP was generated by cloning PCR amplified N/K-ChR2-eYFP (P21/P22) using pGEM-N/K-ChR-eYFP as template in SalI restricted pGREG506-PTEF1.

Plasmid pGREG576-TRPV1 was generated by cloning PCR amplified TRPV1 (P23/P24) using pcDNA3.1-TRPV1 [54] as template in SalI restricted pGREG576.

CRISPR/Cas9 plasmids were generated by using KpnI and PmeI restricted pCAS9c [43] with corresponding gRNA primers for plasmid assembling with the NEBuilder: P3/P4 for pCas9c-CAN1, P9/P10 for pCas9c-kanr and P15/P16 for pCAS9c-YPRCΔ15. The protospacer sequences were designed by using the ATUM gRNA Design Tool (https://www.atum.bio/eCommerce/cas9/input).

The polycistronic β-carotene biosynthetic pathway (PGAP-crtYB-T2A-crtI-T2A-crtE-TTEF1) was PCR amplified (P1/P2) from pUDC082 as template. carX was PCR amplified (P7/P8) from pGEX-carX as template. crtI was PCR amplified (P13/P14) from YIplac211-YB/I/E as template.

Colony PCRs were performed with OneTaq 2X Master Mix in Standard Buffer (NEB) according to manufacturer’s instructions with following modifications: To prepare DNA template, cells from a single colony were suspended in 30 μl of 0.02% SDS, incubated 10 min at 95°C and vortexed vigorously for 1 min. 0.5 μl of the cell suspension was used as template for the PCR reaction with corresponding colony PCR primers.

pUDC082 was a gift from Jules Beekwilder [41], pGEX-carX from Salim Al-Babili [43], and YIplac211-YB/I/E from Gerhard Sandmann [40], and pcDNA3.1-TRPV1 from Makoto Tominaga [54].

Yeast strains

S. cerevisiae strains used in this study are listed in Table 2.

Table 2. Yeast cells used in this study.

name genotype reference
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [55]
PLY240 MATa; his3Δ200; leu2-3,112; trp1Δ901; ura3-52; suc2Δ9; trk1Δ51; trk2Δ50::loxP-kanMX-loxP [37]
SHY1 PLY240; can1::PGAP-crtYB-T2A-crtI-T2A-crtE-TTEF1 This study
SHY2 SHY1; trk2Δ50::loxP-PTEF1-kanr::carX-TTEF1-loxP This study
SHY3 SHY1; YPRCΔ15::PGAP-crtI-TCYC1 This study
SHY4 SHY3; trk2Δ50::loxP-PTEF1-kanr::carX-TTEF1-loxP This study

All yeast strains used in this study and corresponding genotypes are listed in this table.

Engineering of an all-trans retinal producing trk1Δtrk2Δ yeast strain

In order to generate a βproducing yeast strain, the K+-uptake deficient strain PLY240 was co-transformed with pCas9c-CAN1 and the PCR amplified polycistronic β-carotene biosynthetic pathway (PGAP-crtYB-T2A-crtI-T2A-crtE-TTEF). Transformed cells were spread on SD-ura medium +100 mM KCl and grown for 3 days to select for the presence of the pCas9c-CAN1plasmid. Colonies showing yellow color indicated production of β-carotene and therefore presence of the polycistronic β-carotene pathway. Randomly selected yellow colonies were analyzed by colony PCR (P5/P6) for correct integration of the polycistronic β-carotene biosynthetic pathway in the CAN1 locus. The PLY240 strain containing the correctly integrated polycistronic β-carotene biosynthetic pathway in the CAN1 locus was dubbed SHY1.

SHY1 cells were co-transformed with pCas9c-kanr and the PCR amplified carX to generate SHY2. Transformed cells were selected on SD-ura medium +100 mM KCl. Decrease in intensity of yellow color indicated genomic integration of carX. Randomly selected colorless cells were analyzed by colony PCR (P11/P12) for correct integration of carX in the kanr locus.

SHY1 cells were co-transformed with pCas9c-YPRCΔ15 and the PCR amplified crtI to generate SHY3. Transformed cells were selected on SD-ura medium +100 mM KCl. Coloring of cells indicated genomic integration of crtI. Randomly selected orange colonies were analyzed by colony PCR (P17/P18) for correct localized integration of crtI in the YPRCΔ1 locus.

SHY4 was generated by co-transforming SHY3 cells with pCas9c-kanr and the PCR amplified carX. Transformed cells were selected on SD-ura medium +100 mM KCl. Colorless cells indicated genomic integration of carX. Randomly selected colorless cells were analyzed by colony PCR (P11/P12) for correct integration of carX in the kanr locus.

In order to remove the pCAS9c plasmids from successfully transformed and positively PCR-tested cells, the respective cells were transferred to complex YPD medium + 100 mM KCl and subjected to three serial overnight passages. From the final overnight culture, 100–200 cells (1:10.000 dilution from OD600 = 1.0) were plated on YPD + 100 mM KCl agar plates and grown for 2 days. Colonies were picked and streaked on SD-ura + 100 mM KCl for counter selection. Cells which did grow on YPD + 100 mM KCl, but not on SD-ura + 100 mM KCl were plasmid free and used for further work.

All-trans retinal extraction

For all-trans-retinal extraction a freshly grown overnight culture (YPD +100 mM KCl) of cells was harvested by centrifugation (5 min, 4000 rpm, 4°C). The pellet was washed twice with ice cold 5 mL ddH2O and the supernatant was removed. The pellet was resuspended in 1 mL 100% EtOH and transferred in a 1.5 mL reaction tube. 500 μl of 0.5 mm Zirconia/glass beads (Carl Roth) were added and the cells were homogenized three times for 60 sec on a Minilys® Homogenizer (Bertin Technologies). After each round of bead beating the suspension was cooled on ice for 60 sec. The suspension was centrifuged (1 min, 13000 rpm, 4°C) and the supernatant containing the carotenoids was transferred to a vial for UPLC analysis. The vial was anaerobized using 4 times alternating degassing by a vacuum pump and gassing with nitrogen.

UPLC analysis

UPLC analysis of the ethanol cell extract from SHY4 cells with 5 μM all-trans-retinal as reference was kindly performed by Dr. Markus Krischke at the University of Würzburg as described elsewhere [10].

Yeast media

The host strains BY4741 and PLY240 were routinely cultured in YPD (2% glucose; 2% peptone; 1% yeast extract), which was supplemented by 100mM KCl for PLY240.

Strains harboring plasmids with the URA3 marker were selected and grown in SD-ura (2% glucose; 0.69% yeast nitrogen base without amino acids; 0.077% CSM Drop-out -Ura). Agar media contained 2% agar-agar. K+ and Na+ concentrations were adjusted with KCl or NaCl to the indicated concentrations.

For growth tests in media containing K+ concentrations below 7 mM (intrinsic level of standard SD media) Synthetic Defined Arginine Phosphate (SDAP) media [56, 57] was used, which is composed of 10 mM arginine, 2% glucose, 2 mM MgSO4, 0.2 mM CaCl2, 1% trace elements (13 μM FeNaEDTA, 8 μM H3BO3, 0.25 μM CuSO4, 0.6 μM KI, 2.7 μM MnSO4, 1 μM Na2MoO4, 2.5 μM ZnSO4, 0.5 μM CoCl2, 0.5 μM NiCl2), 1% vitamins (2 μg/l biotin, 400 μg/l Ca-panthotenate, 2 μg/l folic acid, 200 μg/l inositol, 400 μg/l niacin, 200 μg/l p-aminobenzoic acid, 400 μg/l pyridoxine hydrochloride, 200 μg/l riboflavin, 400 μg/l thiamine hydrochloride), 50 mg/l His, 50 mg/l Trp, 50 mg/l Leu. The required K+ concentration was added as KCl and pH was adjusted to 5.5 with 85% H3PO4.

Oligonucleotides and plasmids

All oligonucleotides used are listed in Table 3. PCR was performed by using the Q5® Hot Start High-Fidelity 2X Master Mix (NEB GmbH, Frankfurt, Germany) according to manufacturer’s instructions. Plasmids employed and generated in this study are listed in Table 1.

Table 3. Oligonucleotides used in this study.

name sequence (5’- 3’) amplicon
P1 (fw) TCTGTACTTCTCCTTCATCTTCATCACCTATGCCATGACCAATCCTTTGCCGTAGTTTCAACGTATG polycistronic β-carotene pathway: PGAP-crtYB-T2A-crtI-T2A-crtE-TTEF1
P2 (rv) CCGACGAGAGTAAATGGCGAGGATACGTTCTCTATGGCAGTATAGCGACCAGCATTCACATACGATTGACG polycistronic β-carotene pathway: PGAP-crtYB-T2A-crtI-T2A-crtE-TTEF1
P3 (fw) GATACGTTCTCTATGGAGGAGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG gRNA-CAN1
P4 (rv) TCCTCCATAGAGAACGTATCGATCATTTATCTTTCACTGCGGAG gRNA-CAN1
P5 (fw) GAGATAGATACATGCGTGGGTC colony PCR:
polycistronic β-carotene pathway in CAN1
P6 (rv) GATGCCACGGTATTTCAAAG colony PCR:
polycistronic β-carotene pathway in CAN1
P7 (fw) CACATCACATCCGAACATAAACAACCATGAAGTTTCTGCAACAAAATTCCTTCACACAAACG carX
P8 (rv) CAAGAATCTTTTTATTGTCAGTACTGATTATCATCCAACAGCTTTCTCCAACTTCTCTCG carX
P9 (fw) TTACTCACCACTGCGATCCCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG gRNA-kanr
P10 (rv) GGGATCGCAGTGGTGAGTAAGATCATTTATCTTTCACTGCGGAG gRNA-kanr
P11 (fw) CATCTGGGCAGATGATGTCG colony PCR:
carX in kanr
P12 (rv) GTGTCGGATGACTTCTTCTACG colony PCR:
carX in kanr
P13 (fw) AGAAAGAAAAACTAACACATTAATGTAGTTTTAAAATTTCAAATCCGAACAACAGAGCATAGGGTTTCGCAAAAGAGGATCCCCGGGTACCCAGTTCGAG PGAP-crtI-TCYC1
P14 (rv) TAGCACAATAATACCGTGTAGAGTTCTGTATTGTTCTTCTTAGTGCTTGTATATGCTCATCCCGACCTTCCATTCTGGAATTCGAGCTCGGTACCGGCCG PGAP-crtI-TCYC1
P15 (fw) ATATGTTTGGTTTCGATTGTGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAG gRNA-YPRCΔ15
P16 (rv) ACAATCGAAACCAAACATATGATCATTTATCTTTCACTGCGGAG gRNA-YPRCΔ15
P17 (fw) CAAGTTCTTGGTTTCAGGCC colony PCR:
crtI in YPRCΔ15
P18 (rv) ATAAAGCAGCCGCTACCAAA colony PCR:
crtI in YPRCΔ15
P19 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGGATTATGGAGGCGCCCTG ChR2-eYFP
P20 (rv) GCGTGACATAACTAATTACATGACTCGAGGTCGACTTACTTGTACAGCTCGTCCATGCC ChR2-eYFP
P21 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGCGACCCCAAATACTCCTCTTG N/K-ChR2-eYFP
P22 (rv) GCGTGACATAACTAATTACATGACTCGAGGTCGACTTAAACTTCATTTTCATAGCAAAATCTAGACTTGTACAGCTCGTC N/K-ChR2-eYFP
P23 (fw) GAATTCGATATCAAGCTTATCGATACCGTCGACAATGGAACAACGGGCTAGCTTA GFP-TRPV1
P24 (rv) GCGTGACATAACTAATTACATGACTCGAGGTCGACTTATTTCTCCCCTGGGACCA GFP-TRPV1

The underlined parts of the sequence mark homology regions of the overhang primers for NEBuilder-based cloning.

For all cloning steps the NEBuilder HiFi DNA Assembly Master Mix (NEB GmbH, Frankfurt, Germany) was used. Generated plasmids were amplified in E. coli DH5α and sequence verified by Sanger sequencing (Microsynth SeqlabGmbH, Göttingen, Germany).

Yeast media

Strain PLY240 was routinely cultured in YPD + 100 mM KCl (2% glucose; 2% peptone; 1% yeast extract; 100 mM KCl). PLY240 strains harboring plasmids were selected and grown in corresponding synthetic defined (SD) drop-out media (2% glucose; 0.69% yeast nitrogen base without amino acids; 0.077% CSM Drop-out -Ura or 0.067% CSM Dropout -Leu-Ura or 0.062% CSM Drop-out-Leu-Trp-Ura). Agar media contained 2% agar (AppliChem, Darmstadt, Germany).

Yeast transformation

Transformation of yeast strain PLY240 with the generated plasmids was performed by using the Frozen-EZ Yeast Transformation II kit (Zymo Research Europe GmbH, Freiburg, Germany) according to manufacturer’s instructions. For selection, transformed yeast were streaked onto SD-ura +100 mM KCl agar plates, incubated at 30°C and colonies were picked after 72 h.

Luminometric assay

Aequorin-based luminometry was used to monitor changes in intracellular calcium concentration in intact yeast cells. For that, cells were grown overnight in the dark in 10 mL SGal-leu medium containing 3 μL of 6.8 mM coelenterazine. Cells were harvested by centrifugation, resuspended in an incubation medium (10 mM Tris/MES, 0.1 mM CaCl2, 10 g/L glucose at pH 7) to an OD600 = 2 and incubated for 30 min at 30°C in the dark. A 100 μL aliquot of the cell suspension was loaded into the luminometer (Lumac/3M, Abimed). 10 s after start of the recording, 10 μM capsaicin was added by injecting 100 μL of test medium (same as incubation medium plus 20 μM capsaicin) into the cuvette. Data acquisition was done with Labview Signal Express (National Instruments) and a NI USB-6009 interface (National Instruments).

Growth assays

All strains were grown overnight in appropriate SD + 100 mM KCl medium. Grown cells were washed twice with ddH2O and set to OD600 = 1.0. 10-fold dilutions were spotted on corresponding SD agar plates + 1 mM KCl and as a control on plates with + 100 mM KCl. Plates were incubated at 30°C for 72 h and illuminated by an 8W Albrillo LED Daylight Lamp with constant 300 μEinstein or placed in a sealed box to avoid any illumination. This device consists of a square, 5 mm thick aluminum base plate with a side length of 300 mm to deflect the heat generated by 12 WINGER® WEPBL3-S1 Power (465nm) 3W LEDs, which are centered at the appropriate spacing for wells of a 24 well plate. This device, called "light plate", serves as base for a "growth plate". On this growth plate, 12 wells are illuminated at a time and 12 remain non-illuminated. The illumination intensity can be modulated by the applied voltage to the LEDs or the distance between them and the "light plate". Since the use of the "light plate" did not allow continuous tracking of cell growth, the OD600 was instead measured manually at regular intervals with a plate reader at on a BioTek EpochTM 2 Microplate Spectrophotometer (Aligen Santa Clara, Ca USA).

In an alternative approach cells were incubated as described above in 24 well plates and the latter were incubated for 48 h at a constant temperature of 30°C in a BioTek EpochTM 2 Microplate Spectrophotometer (Aligen Santa Clara, Ca USA). The well plates, sealed with Breathe-Easy sealing membranes (Merck, Darmstadt, Germany), were illuminated in 30 sec intervals with blue light of 500 nm. The latter served both to activate the ChR variant of interest and to monitor the OD500.

To determine the maximum growth rate (μmax), the growth curves were first smoothed by calculating the moving average (window width = 5 data points). Subsequently, the growth rate μ for two neighboring data points was determined by Eq 1 calculating the difference quotient

μt+Δt2=OD500t+ΔtOD500tΔt (1)

with t being the time and Δt the time between two neighboring data points. The highest value was then used as μmax.

Confocal microscopy

Cells expressing eGFP or eYFP tagged proteins were imaged on a Leica TCS SP5 II spectral confocal laser scanning microscope (Leica Microsystems, Heidelberg Germany) equipped with a 100-x oil objective (HCX PL APO CS 100x/1.44). GFP/YFP was excited at 488 nm and emission was detected between 510–585 nm.

The intensity of yellow color in Fig 2 was analyze with Fiji imaging software [58] using the color deconvolution plugin tool. Regions of interest on the agar plates and on the background were unmixed into three distinct colors of which one was yellow. The intensity in the yellow channel from a region of interest in the background was subtracted from the respective area over the agar plates.

Plasmids for electrophysiology

The ChRs in the pGEMHE vector was from the stock of the Nagel lab. Point mutations were introduced by QuikChange PCR. To remove the original plasmid, the PCR mix after amplification was incubated with DpnI enzyme for 3 hours at 37°C. All constructs were verified by automated DNA sequencing.

Electrophysiology in oocytes

Oocytes Xenopus laevis were obtained from the Department of Molecular Plantphysiology and Biophysics—Botany I of the University Wuerzburg. The laparotomy to obtain oocytes from Xenopus was carried out in accordance with the principles of the Basel Declaration and recommendations of Landratsamt Wuerzburg Veterinaeramt. The protocol under License #70/14 from Landratsamt Wuerzburg, Veterinaeramt, was approved in written form by the responsible veterinarian.

X. laevis oocytes were injected with 30 ng cRNA and incubated in medium containing 10 μM all-trans-retinal for 2 or 3 days before measurement. Two-electrode voltage-clamp recordings of photo-currents were made in Ringer’s solution (110 mM NaCl, 5 mM KCl, 2 mM BaCl2, 1 mM MgCl2, 5 mM HEPES, pH 7.6) or in solutions with high concentration of Na+ or K+ (120 mM NaCl or KCl, 2 BaCl2, 5 mM HEPES, pH 7.6) or in solutions with low concentration of Na+/K+(1 mM NaCl or KCl, 119 NMG, 2 BaCl2, 5 mM HEPES, pH 7.6). Electrode capillaries were filled with 3 M KCl. Stimulation and data acquisition were controlled with an AD-DA converter (Digidata 1322A, Axon Instruments) and WinWCP software (Strathclyde University, United Kingdom). A 473 nm laser (Changchun New Industries Optoelectronics Tech) were used as light sources.

Statistics

Data form yeast growth assays in liquid culture (Figs 5B, 5C and 6A–6D) and electrophysiological recordings of photocurrents (Fig 4B and 4E) are mean values ± standard deviation from ≥ 3 independent biological replicates. All images of yeast growth experiments on agar plats (Fig 1B, 1D, S1 and S2B Figs), images of yeast cells (Figs 1A, 2A, 3A, 3B and 5A), Xenopus laevis oocytes (4C), HPLC spectra (Fig 3C) and electrical/ fluorescent trajectories (figs 1C and 4D) are representative examples from ≥ 3 independent biological replicates. Statistical significance was calculated with student t-test.

Supporting information

S1 Fig. Functional complementation of SHY4 cells by K+ channel.

(A) Fluorescence images of SHY4 cells transiently expressing GFP tagged K+ channel KcvPBCV1 (KcvPBCV1::GFP). Scale bar = 5 μm. (B) Serial dilutions of K+ uptake deficient SHY4 cells transformed with KcvPBCV1::GFP plasmid or the corresponding empty vector (ev). Cells spotted on SD-ura plates with either high (100 mM KCl, top) or without K+ supplementation and incubated for 72h. KcvPBCV1 rescues growth of SHY4 cells on SD-ura medium without additional K+ (bottom row). For experimental details see [1]. [1] Gebhardt M, Hoffgaard F, Hamacher K, Kast SM, Moroni A, Thiel G. Membrane anchoring and interaction between transmembrane domains is crucial for K+ channel function. J. Biol. Chem. 2011; 286:11299–11306.

(PDF)

S2 Fig. N/K-ChR2-eYFP expression does not restore growth of SHY4 cells on low K+ agar medium.

Serial dilutions of all-trans retinal producing K+ uptake deficient SHY4 cells transformed with either a plasmid for constitutive expression of N/K-ChR2-eYFP or the corresponding empty vector (ev). Cells spotted on SD-ura plates with either high (100 mM KCl, top) or a without K+ supplementation and incubated for 72h. Colonies grow only on SD-ura medium with high K+ concentration independently of incubation in the dark (left) or in blue light (right).

(PDF)

S1 Data

(XLSX)

Acknowledgments

We would like to thank Markus Krischke (Uni. of Würzburg) for HPLC analysis and Tobias Meckel (TU Darmstadt) for help with image analysis.

Data Availability

All relevant data are within the paper and its Supporting information files.

Funding Statement

GT; AM: European Research Council GT:German Research Foundation. GN: German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Deisseroth K. Optogenetics. Nature methods. 2011; 8:26–9. Epub 2010/12/20. doi: 10.1038/nmeth.f.324 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Mühlhäuser WWD, Fischer A, Weber W, Radziwill G. Optogenetics—Bringing light into the darkness of mammalian signal transduction. Biochimica et biophysica acta. Molecular cell research. 2017; 1864:280–92. Epub 2016/11/11. doi: 10.1016/j.bbamcr.2016.11.009 . [DOI] [PubMed] [Google Scholar]
  • 3.Boyden ES, Zhang F, Bamberg E, Nagel G, Deisseroth K. Millisecond-timescale, genetically targeted optical control of neural activity. Nat Neurosci. 2005; 8:1263–8. Epub 2005/08/14. doi: 10.1038/nn1525 . [DOI] [PubMed] [Google Scholar]
  • 4.Lima SQ, Miesenböck G. Remote control of behavior through genetically targeted photostimulation of neurons. Cell. 2005; 121:141–52. doi: 10.1016/j.cell.2005.02.004 . [DOI] [PubMed] [Google Scholar]
  • 5.Nagel G, Brauner M, Liewald JF, Adeishvili N, Bamberg E, Gottschalk A. Light activation of channelrhodopsin-2 in excitable cells of Caenorhabditis elegans triggers rapid behavioral responses. Current biology: CB. 2005; 15:2279–84. doi: 10.1016/j.cub.2005.11.032 . [DOI] [PubMed] [Google Scholar]
  • 6.Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annual review of neuroscience. 2011; 34:389–412. doi: 10.1146/annurev-neuro-061010-113817 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Boyden ES. A history of optogenetics: the development of tools for controlling brain circuits with light. F1000 Biology Reports. 2011; 3:11. Epub 2011/05/03. doi: 10.3410/B3-11 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Agus V, Janovjak H. Optogenetic methods in drug screening: technologies and applications. Curr Opin Biotechnol. 2017; 48:8–14. Epub 2017/03/06. doi: 10.1016/j.copbio.2017.02.006 . [DOI] [PubMed] [Google Scholar]
  • 9.Nagel G, Ollig D, Fuhrmann M, Kateriya S, Musti AM, Bamberg E, et al. Channelrhodopsin-1: a light-gated proton channel in green algae. Science. 2002; 296:2395–8. doi: 10.1126/science.1072068 . [DOI] [PubMed] [Google Scholar]
  • 10.Nagel G, Szellas T, Huhn W, Kateriya S, Adeishvili N, Berthold P, et al. Channelrhodopsin-2, a directly light-gated cation-selective membrane channel. Proc Natl Acad Sci U S A. 2003; 100:13940–5. Epub 2003/11/13. doi: 10.1073/pnas.1936192100 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Schneider F, Grimm C, Hegemann P. Biophysics of Channelrhodopsin. Annual review of biophysics. 2015; 44:167–86. doi: 10.1146/annurev-biophys-060414-034014 . [DOI] [PubMed] [Google Scholar]
  • 12.Schneider F, Gradmann D, Hegemann P. Ion selectivity and competition in channelrhodopsins. Biophysical Journal. 2013; 105:91–100. doi: 10.1016/j.bpj.2013.05.042 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Lin JY, Knutsen PM, Muller A, Kleinfeld D, Tsien RY. ReaChR: a red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation. Nat Neurosci. 2013; 16:1499–508. Epub 2013/09/01. doi: 10.1038/nn.3502 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kleinlogel S, Feldbauer K, Dempski RE, Fotis H, Wood PG, Bamann C, et al. Ultra light-sensitive and fast neuronal activation with the Ca2+-permeable channelrhodopsin CatCh. Nat Neurosci. 2011; 14:513–8. Epub 2011/03/13. doi: 10.1038/nn.2776 . [DOI] [PubMed] [Google Scholar]
  • 15.Berndt A, Schoenenberger P, Mattis J, Tye KM, Deisseroth K, Hegemann P, et al. High-efficiency channelrhodopsins for fast neuronal stimulation at low light levels. Proc Natl Acad Sci U S A. 2011; 108:7595–600. Epub 2011/04/19. doi: 10.1073/pnas.1017210108 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Gunaydin LA, Yizhar O, Berndt A, Sohal VS, Deisseroth K, Hegemann P. Ultrafast optogenetic control. Nat Neurosci. 2010; 13:387–92. Epub 2010/01/17. doi: 10.1038/nn.2495 . [DOI] [PubMed] [Google Scholar]
  • 17.Bedbrook CN, Yang KK, Rice AJ, Gradinaru V, Arnold FH. Machine learning to design integral membrane channelrhodopsins for efficient eukaryotic expression and plasma membrane localization. PLoS Comput Biol. 2017; 13:e1005786. Epub 2017/10/23. doi: 10.1371/journal.pcbi.1005786 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Govorunova EG, Sineshchekov OA, Janz R, Liu X, Spudich JL. NEUROSCIENCE. Natural light-gated anion channels: A family of microbial rhodopsins for advanced optogenetics. Science. 2015; 349:647–50. Epub 2015/06/25. doi: 10.1126/science.aaa7484 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Govorunova EG, Gou Y, Sineshchekov OA, Li H, Lu X, Wang Y, et al. Kalium channelrhodopsins are natural light-gated potassium channels that mediate optogenetic inhibition. Nat Neurosci. 2022; 25:967–74. Epub 2022/06/20. doi: 10.1038/s41593-022-01094-6 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Wietek J, Beltramo R, Scanziani M, Hegemann P, Oertner TG, Wiegert JS. An improved chloride-conducting channelrhodopsin for light-induced inhibition of neuronal activity in vivo. Sci Rep. 2015; 5:14807. Epub 2015/10/07. doi: 10.1038/srep14807 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Berndt A, Lee SY, Ramakrishnan C, Deisseroth K. Structure-guided transformation of channelrhodopsin into a light-activated chloride channel. Science. 2014; 344:420–4. doi: 10.1126/science.1252367 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Govorunova EG, Sineshchekov OA, Spudich JL. Emerging Diversity of Channelrhodopsins and Their Structure-Function Relationships. Frontiers in cellular neuroscience. 2021; 15:800313. Epub 2022/01/24. doi: 10.3389/fncel.2021.800313 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Rozenberg A, Kaczmarczyk I, Matzov D, Vierock J, Nagata T, Sugiura M, et al. Rhodopsin-bestrophin fusion proteins from unicellular algae form gigantic pentameric ion channels. Nat Struct Mol Biol. 2022; 29:592–603. Epub 2022/06/16. doi: 10.1038/s41594-022-00783-x . [DOI] [PubMed] [Google Scholar]
  • 24.Minor DL. Searching for interesting channels: pairing selection and molecular evolution methods to study ion channel structure and function. Molecular bioSystems. 2009; 5:802–10. Epub 2009/06/19. doi: 10.1039/b901708a . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Anderson JA, Huprikar SS, Kochian LV, Lucas WJ, Gaber RF. Functional expression of a probable Arabidopsis thaliana potassium channel in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1992; 89:3736–40. doi: 10.1073/pnas.89.9.3736 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Gebhardt M, Henkes LM, Tayefeh S, Hertel B, Greiner T, van Etten JL, et al. Relevance of lysine snorkeling in the outer transmembrane domain of small viral potassium ion channels. Biochemistry. 2012; 51:5571–9. Epub 2012/07/06. doi: 10.1021/bi3006016 . [DOI] [PubMed] [Google Scholar]
  • 27.Chatelain FC, Gazzarrini S, Fujiwara Y, Arrigoni C, Domigan C, Ferrara G, et al. Selection of inhibitor-resistant viral potassium channels identifies a selectivity filter site that affects barium and amantadine block. PLOS ONE. 2009; 4:e7496. Epub 2009/10/16. doi: 10.1371/journal.pone.0007496 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Bagriantsev SN, Minor DL. Using yeast to study potassium channel function and interactions with small molecules. Methods in molecular biology (Clifton, N.J.). 2013; 995:31–42. doi: 10.1007/978-1-62703-345-9_3 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Balss J, Papatheodorou P, Mehmel M, Baumeister D, Hertel B, Delaroque N, et al. Transmembrane domain length of viral K+ channels is a signal for mitochondria targeting. Proc Natl Acad Sci U S A. 2008; 105:12313–8. Epub 2008/08/21. doi: 10.1073/pnas.0805709105 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Cosentino C, Alberio L, Gazzarrini S, Aquila M, Romano E, Cermenati S, et al. Optogenetics. Engineering of a light-gated potassium channel. Science. 2015; 348:707–10. Epub 2015/05/07. doi: 10.1126/science.aaa2787 . [DOI] [PubMed] [Google Scholar]
  • 31.Hoi H, Qi Z, Zhou H, Montemagno CD. Enhanced overexpression, purification of a channelrhodopsin and a fluorescent flux assay for its functional characterization. J Biotechnol. 2018; 281:99–105. Epub 2018/07/04. doi: 10.1016/j.jbiotec.2018.07.006 . [DOI] [PubMed] [Google Scholar]
  • 32.Zhang L, Wang K, Ning S, Pedersen PA, Duelli AS, Gourdon PE. Isolation and Crystallization of the D156C Form of Optogenetic ChR2. Cells. 2022; 11:895. Epub 2022/03/05. doi: 10.3390/cells11050895 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Terpitz U, Raimunda D, Westhoff M, Sukhorukov VL, Beaugé L, Bamberg E, et al. Electrofused giant protoplasts of Saccharomyces cerevisiae as a novel system for electrophysiological studies on membrane proteins. Biochim Biophys Acta. 2008; 1778:1493–500. Epub 2008/04/01. doi: 10.1016/j.bbamem.2008.03.015 . [DOI] [PubMed] [Google Scholar]
  • 34.Ullrich S, Gueta R, Nagel G. Degradation of channelopsin-2 in the absence of retinal and degradation resistance in certain mutants. Biological chemistry. 2013; 394:271–80. doi: 10.1515/hsz-2012-0256 . [DOI] [PubMed] [Google Scholar]
  • 35.Zhou Y, Ding M, Gao S, Yu-Strzelczyk J, Krischke M, Duan X, et al. Optogenetic control of plant growth by a microbial rhodopsin. Nat Plants. 2021; 7:144–51. Epub 2021/02/16. doi: 10.1038/s41477-021-00853-w . [DOI] [PubMed] [Google Scholar]
  • 36.Mollaaghababa R, Davidson FF, Kaiser C, Khorana HG. Structure and function in rhodopsin: expression of functional mammalian opsin in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A. 1996; 93:11482–6. doi: 10.1073/pnas.93.21.11482 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Bertl A, Ramos J, Ludwig J, Lichtenberg-Fraté H, Reid J, Bihler H, et al. Characterization of potassium transport in wild-type and isogenic yeast strains carrying all combinations of trk1, trk2 and tok1 null mutations. Molecular microbiology. 2003; 47:767–80. doi: 10.1046/j.1365-2958.2003.03335.x . [DOI] [PubMed] [Google Scholar]
  • 38.Bamann C, Gueta R, Kleinlogel S, Nagel G, Bamberg E. Structural guidance of the photocycle of channelrhodopsin-2 by an interhelical hydrogen bond. Biochemistry. 2010; 49:267–78. doi: 10.1021/bi901634p . [DOI] [PubMed] [Google Scholar]
  • 39.Bihler H, Slayman CL, Bertl A. NSC1: a novel high-current inward rectifier for cations in the plasma membrane of Saccharomyces cerevisiae. FEBS letters. 1998; 432:59–64. doi: 10.1016/s0014-5793(98)00832-1 . [DOI] [PubMed] [Google Scholar]
  • 40.Verwaal R, Wang J, Meijnen J-P, Visser H, Sandmann G, van den Berg JA, et al. High-level production of beta-carotene in Saccharomyces cerevisiae by successive transformation with carotenogenic genes from Xanthophyllomyces dendrorhous. Appl Environ Microbiol. 2007; 73:4342–50. Epub 2007/05/11. doi: 10.1128/AEM.02759-06 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Beekwilder J, van Rossum HM, Koopman F, Sonntag F, Buchhaupt M, Schrader J, et al. Polycistronic expression of a β-carotene biosynthetic pathway in Saccharomyces cerevisiae coupled to β-ionone production. J Biotechnol. 2014; 192 Pt B:383–92. Epub 2014/01/28. doi: 10.1016/j.jbiotec.2013.12.016 . [DOI] [PubMed] [Google Scholar]
  • 42.Degreif D, Kremenovic M, Geiger T, Bertl A. Preloading budding yeast with all-in-one CRISPR/Cas9 vectors for easy and high-efficient genome editing. Journal of Biological Methods. 2018; 5:e98. Epub 2018/09/12. doi: 10.14440/jbm.2018.254 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Prado-Cabrero A, Scherzinger D, Avalos J, Al-Babili S. Retinal biosynthesis in fungi: characterization of the carotenoid oxygenase CarX from Fusarium fujikuroi. Eukaryotic Cell. 2007; 6:650–7. Epub 2007/02/09. doi: 10.1128/EC.00392-06 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Flagfeldt DB, Siewers V, Le Huang, Nielsen J. Characterization of chromosomal integration sites for heterologous gene expression in Saccharomyces cerevisiae. Yeast (Chichester, England). 2009; 26:545–51. doi: 10.1002/yea.1705 . [DOI] [PubMed] [Google Scholar]
  • 45.Yang S. Characterization and engineering of photoreceptors with improved properties for optogenetic application. Doctoralthesis, Universität Würzburg. 2022. https://opus.bibliothek.uni-wuerzburg.de/frontdoor/index/index/docId/20527.
  • 46.Scholz N, Guan C, Nieberler M, Grotemeyer A, Maiellaro I, Gao S, et al. Mechano-dependent signaling by Latrophilin/CIRL quenches cAMP in proprioceptive neurons. eLife. 2017; 6. Epub 2017/08/08. doi: 10.7554/eLife.28360 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Duan X, Nagel G, Gao S. Mutated Channelrhodopsins with Increased Sodium and Calcium Permeability. Applied Sciences. 2019; 9:664. doi: 10.3390/app9040664 [DOI] [Google Scholar]
  • 48.Haro R, Garciadeblas B, Rodriguez-Navarro A. A novel P-type ATPase from yeast involved in sodium transport. FEBS letters. 1991; 291:189–91. doi: 10.1016/0014-5793(91)81280-l . [DOI] [PubMed] [Google Scholar]
  • 49.Prior C, Potier S, Souciet J-L, Sychrova H. Characterization of the NHA1 gene encoding a Na + /H + -antiporter of the yeast Saccharomyces cerevisiae. FEBS letters. 1996; 387:89–93. doi: 10.1016/0014-5793(96)00470-x . [DOI] [PubMed] [Google Scholar]
  • 50.Nass R, Cunningham KW, Rao R. Intracellular sequestration of sodium by a novel Na+/H+ exchanger in yeast is enhanced by mutations in the plasma membrane H+-ATPase. Insights into mechanisms of sodium tolerance. The Journal of biological chemistry. 1997; 272:26145–52. doi: 10.1074/jbc.272.42.26145 . [DOI] [PubMed] [Google Scholar]
  • 51.Jansen G, Wu C, Schade B, Thomas DY, Whiteway M. Drag&Drop cloning in yeast. Gene. 2005; 344:43–51. Epub 2004/12/10. doi: 10.1016/j.gene.2004.10.016 . [DOI] [PubMed] [Google Scholar]
  • 52.Degreif D, Cucu B, Budin I, Thiel G, Bertl A. Lipid determinants of endocytosis and exocytosis in budding yeast. Biochimica et biophysica acta. Molecular and cell biology of lipids. 2019; 1864:1005–16. Epub 2019/03/24. doi: 10.1016/j.bbalip.2019.03.007 . [DOI] [PubMed] [Google Scholar]
  • 53.Batiza AF, Schulz T, Masson PH. Yeast respond to hypotonic shock with a calcium pulse. The Journal of biological chemistry. 1996; 271:23357–62. doi: 10.1074/jbc.271.38.23357 . [DOI] [PubMed] [Google Scholar]
  • 54.Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997; 389:816–24. doi: 10.1038/39807 . [DOI] [PubMed] [Google Scholar]
  • 55.Brachmann CB, Davies A, Cost GJ, Caputo E, Li J, Hieter P, et al. Designer deletion strains derived from Saccharomyces cerevisiae S288C: a useful set of strains and plasmids for PCR-mediated gene disruption and other applications. Yeast (Chichester, England). 1998; 14:115–32. doi: . [DOI] [PubMed] [Google Scholar]
  • 56.Rodríguez-Navarro A, Ramos J. Dual system for potassium transport in Saccharomyces cerevisiae. Journal of Bacteriology. 1984; 159:940–5. doi: 10.1128/jb.159.3.940-945.1984 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57.Ramos J, Contreras P, Rodrguez-Navarro A. A potassium transport mutant of Saccharomyces cerevisiae. Arch Microbiol. 1985; 143:88–93. doi: 10.1007/BF00414774 [DOI] [Google Scholar]
  • 58.Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nature methods. 2012; 9:676–82. Epub 2012/06/28. doi: 10.1038/nmeth.2019 . [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Patrick Lajoie

20 Feb 2023

PONE-D-22-35053Tailoring baker’s yeast Saccharomyces cerevisiae for functional testing of ChannelrhodopsinPLOS ONE

Dear Dr. Thiel,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Apr 06 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Patrick Lajoie, PhD

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

3. Thank you for stating the following in the Acknowledgments Section of your manuscript: 

    "This work was funded in part by the European Research Council (ERC; 2015 Advanced Grant 495 (AdG) n. 695078 noMAGIC (G.T. & A.M.) the priority program 

SPP1926 (to GT) and by Projects #374031971, TRR 240 A04 and #417451587 (to G.N.) from DFG, German Research Foundation. We would like to thank Markus Krischke (Uni. of Würzburg) for HPLC analysis and Tobias Meckel (TU Darmstadt) for help with image analysis."

We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. 

Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: 

  "GT; AM: European Research Council

GT:German Research Foundation.

GN:  German Research Foundation.

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."

Please include your amended statements within your cover letter; we will change the online submission form on your behalf.

4. In your Data Availability statement, you have not specified where the minimal data set underlying the results described in your manuscript can be found. PLOS defines a study's minimal data set as the underlying data used to reach the conclusions drawn in the manuscript and any additional data required to replicate the reported study findings in their entirety. All PLOS journals require that the minimal data set be made fully available. For more information about our data policy, please see http://journals.plos.org/plosone/s/data-availability.

"Upon re-submitting your revised manuscript, please upload your study’s minimal underlying data set as either Supporting Information files or to a stable, public repository and include the relevant URLs, DOIs, or accession numbers within your revised cover letter. For a list of acceptable repositories, please see http://journals.plos.org/plosone/s/data-availability#loc-recommended-repositories. Any potentially identifying patient information must be fully anonymized.

Important: If there are ethical or legal restrictions to sharing your data publicly, please explain these restrictions in detail. Please see our guidelines for more information on what we consider unacceptable restrictions to publicly sharing data: http://journals.plos.org/plosone/s/data-availability#loc-unacceptable-data-access-restrictions. Note that it is not acceptable for the authors to be the sole named individuals responsible for ensuring data access.

We will update your Data Availability statement to reflect the information you provide in your cover letter.

5. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

6. Please include your full ethics statement in the ‘Methods’ section of your manuscript file. In your statement, please include the full name of the IRB or ethics committee who approved or waived your study, as well as whether or not you obtained informed written or verbal consent. If consent was waived for your study, please include this information in your statement as well. 

Additional Editor Comments:

The reviewers have raised several points that I believe should be addressed prior acceptance for publication. In particular, while I think asking for a full screen would be a bit too ambitious for publication in PLoS One, I believe the reviewer as a valid point and further characterization of the function of ChR2 in yeast to highlight the power of the model would be beneficial for the readers so they can appreciate this new tool. 

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: I Don't Know

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The manuscript by Höller et el., aims to implement the light-activated membrane channel (Channelrhodopsin) in the budding yeast S. cerevisiae. This is a challenging endeavor since yeast is not producing the chromophore (retinal) enabling Channelrhodopsin function. The authors overcome this problem by engineering the metabolic pathway for retinal biosynthesis in yeast. Finally, functionality of Channelrhodopsin was tested indirectly by measuring the yeast growth under different Na+ and K+ concentrations.

Major comments:

- The functionality of the Channelrhodopsin in yeast was tested using a growth assay under different Na+ and K+ concentrations. These indirect results should be complemented with a direct measurement of channel functionality upon light stimulation.

- The growth curves shown in Figures 5 and 7 were performed using light at 500 nm. The authors mention that this wavelength was used to measure the yeast growth and activate the Channelrhodopsin. For yeast growth curves, measurements must be carried out at 600 nm. Therefore, the authors should use an illumination system coupled to a plate reader to stimulate the yeast cells at 460 nm and read the growth at 600 nm. Please see the illumination systems in the following references PMIDs: 27805047, 31788779, 34431694, and 36457859.

- In Figure 5, the constant darkness condition (control condition) is missing.

- Figure 6 should be moved to supplementary information.

- In Figure 7 (panels B, C, and D), the statistical analysis should be done between constant darkness (control) and blue-light.

- In Figure 7 (panel A), the constant darkness condition (control condition) is missing.

Minor comments:

- In table 1, replace “stuffer” by locus.

Reviewer #2: REVIEWER COMMENTS

In this manuscript, the authors report an engineered and validated Saccharomyces cerevisiae strain that expressed the light-activated Channelrhodopsin 2 (ChR2) that could be used for future screens.

Overall, the authors approach to generate a functional light-activated ion transporter using synthetic biology is interesting. From the abstract, I was looking forward to understanding the proposed engineered yeast system and to see what the potential is. However, the manuscript felt very short to provide a toolbox that might be useful to the research community. I recommend the authors to remove some of the distracting data, to add a substantial amount of data to either (1) perform a screen using their engineered yeast or (2) to characterize ChR2 in yeast. I also recommend the authors to polish the manuscript to make it easier to read.

Major points to address

(1) The first two figures contained failed attempt to expressed ChR2 in yeast, so the authors used a different approach in Fig. 3. Fig. 1 and 2 should be removed to the manuscript as they are distracting and not informative nor helpful for the rest of the data.

(2) The authors stated that N/K-ChR2-eYFP localizes at the plasma membrane (PM) with a subpopulation in endomembrane. However, it seems that the majority of ChR2 is at the vacuole with a small fraction at the PM (Fig. 5A). It will suggest that most of ChR2 is non-functional nor folded properly. The authors should further characterize the expression and localization of ChR2 in yeast. ChR2 should mostly localize at the PM. Therefore, I disagree with the authors statement “When the optimized ChR2-5x, termed N/K-ChR2, was expressed in SHY4 cells, we found that it was also in this organism efficiently sorted to the plasma membrane”.

(3) From Fig. 1 title, the authors stated that ChR2 is properly expressed in yeast. Yes, ChR2 is expressed but I disagree that it is “properly” expressed as most of ChR2 proteins not at the PM and so might not be functional.

(4) In the middle of page 10, the authors stated that the data is “not explicitly shown here”. I suggest reporting the results here or to remove this statement.

(5) The manuscript feels incomplete. The authors should consider performing a screen with their engineered yeast to demonstrate how it can be used and that it can be used successfully. Alternatively, the authors might want to consider characterizing ChR2 in yeast to show that yeast is a powerful vehicle to characterize a protein that will be difficult to study in its endogenous environment. In my opinion, the manuscript is partial without addressing this point.

Minor points to address

(1) Space missing between “Fig.” and numbers as well as between numbers and units (such as 1mM should be 1 mM) through the manuscript.

(2) Please indicate how many biological replicates for experiments in figure legends.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Apr 13;18(4):e0280711. doi: 10.1371/journal.pone.0280711.r002

Author response to Decision Letter 0


5 Mar 2023

Reviewer #1: Major comments:

Reviewer: The functionality of the Channelrhodopsin in yeast was tested using a growth assay under different Na+ and K+ concentrations. These indirect results should be complemented with a direct measurement of channel functionality upon light stimulation.

Our response: The intention of this work was to create an easy test system for a high throughput screening of functional Channelrhodopsins. Our data clearly show in several complementary experiments that the different growth phenotypes of the yeasts can only be explained by the presence of an active blue light stimulated, retinal depending and cation conducting Channelrhodopsin. Our assay is even able to distinguish between two different forms of Channelrhodopsins (Fig. 5/Fig. 7). We don’t see what additional information we would obtain from difficult electrophysiological recordings of photocurrents. In fact the goal of the paper is to show that Channelrhodopsin activity can be assayed without measuring the currents in individual cells.

Reviewer: The growth curves shown in Figures 5 and 7 were performed using light at 500 nm. The authors mention that this wavelength was used to measure the yeast growth and activate the Channelrhodopsin. For yeast growth curves, measurements must be carried out at 600 nm.

Our response: With all respect we disagree with the reviewer. The measurement of growth curves at 600 nm is a convention but this wavelength is from a physical point of view not obligatory. Indeed, there are many examples in the literature (see below) in which growth curves also from yeast were measured at 500 nm. In our experiments this is justified by the fact that we use the same light for stimulating the Channelrhodopsin and for measuring the OD. For readers used to OD600 measurements we have added the information that one OD500 unit is equivalent to 2.3 x 107 cells/ml.

References reporting yeast growth as OD500: Yeung et al. (1999) MBoC; Zühlke et al. (2016) Scientific Reports; Nilsson and Sunnerhagen (2011) RNA; Bernardo et al. (2014) FEMS Yeast Research. This list is not complete but contains Journals like FEMS Yeast Research, which are specialized in work with yeast.

Reviewer: Therefore, the authors should use an illumination system coupled to a plate reader to stimulate the yeast cells at 460 nm and read the growth at 600 nm. Please see the illumination systems in the following references PMIDs: 27805047, 31788779, 34431694, and 36457859.

Our response: We do not see the need for implementing specific light sources. The intention of our paper is to create the biological basis for an easy functional test system. Every potential user can later employ our yeast strains for their specific need. This will eventually require anyway a specific adaptation like growth conditions, light source etc.

Reviewer: In Figure 5, the constant darkness condition (control condition) is missing.

Our response: The clear intention of this experiment is to analyze the negative effect of Na+ on yeast growth in the presence and absence of active Channelrhodosin. We don’t see a rational for comparing the growth data with dark incubated yeast. If the reviewer is concerned about some unexpected effects in the dark we can point to the experiments in Fig. 7. In these complementation experiments it was reasonable to include data on dark grown yeast.

Reviewer: Figure 6 should be moved to supplementary information.

Our response: We have moved Fig. 6 to the supplementary information

Reviewer: In Figure 7 (panels B, C, and D), the statistical analysis should be done between constant darkness (control) and blue-light.

In Figure 7 (panel A), the constant darkness condition (control condition) is missing.

Our response: Again, in both cases we don’t see the information which we would get from these experiments and comparisons with a dark control. Each experiment should address a clear cut question, which is answered by the results. A cross correlation of different conditions does not help to find these answers.

Minor comments:

Reviewer: In table 1, replace “stuffer” by locus.

Our response: The term “stuffer” has been used in the original publication by Jansen et al, 2005, describing construction and use of the pGREG plasmids. For the sake of consistence with the original description we would like to keep this term.

Reviewer #2: Major points to address

Reviewer: (1) The first two figures contained failed attempt to expressed ChR2 in yeast, so the authors used a different approach in Fig. 3. Fig. 1 and 2 should be removed to the manuscript as they are distracting and not informative nor helpful for the rest of the data.

Our response: We understand the suggestion of the reviewer to start the manuscript with the successful part of the experiments. At the same time, we have valid arguments to keep the information presented in Fig. 1 and 2. A general problems is that negative results are rarely published with the effect that the same kind of experiments are repeated over and over by different laboratories. From conversations with colleagues, we think that the present paper is a good frame for reporting also the fact that external feeding of retinal is not sufficient for guaranteeing channelrhodopsin function in yeast.

Reviewer: (2) The authors stated that N/K-ChR2-eYFP localizes at the plasma membrane (PM) with a subpopulation in endomembrane. However, it seems that the majority of ChR2 is at the vacuole with a small fraction at the PM (Fig. 5A).

Our response: With all respect we have the impression that the reviewer misinterprets the anatomy of a yeast cell. Different from pant cells, the yeast vacuole is not filling up most of the inner space of the cell; it can be clearly distinguished from the plasma membrane. To illustrate this have included here two images with wt yeast cells (left) and with yeast cells expressing the GFP taged tonoplast channel YFC1. In both cases it clearly visible that the tonoplast is well separated from the plasma membrane.

The images in our manuscript on ChR2 distribution in the yeast cells show definitely a plasma membrane localization of the protein. The two cells on the bottom-right show strong plasma membrane staining with nearly no other localization (the larger of the two cells) and staining associated with nucleus (ER) in the smaller of the two cells. We are now spelling this out in the revised manuscript and underpin that the functional data are fully supporting this conclusion. A growth complementation in low K+ medium by the expression of ChR2 in blue light can only be achieved by channel activity of this protein in the plasma membrane.

Figures: Left: Transmission light image of wt yeast cells. Right: Overlay of transmission light image and fluorescent signal from GFP taged YFC1.

Reviewer: It will suggest that most of ChR2 is non-functional nor folded properly. The authors should further characterize the expression and localization of ChR2 in yeast. ChR2 should mostly localize at the PM. Therefore, I disagree with the authors statement “When the optimized ChR2-5x, termed N/K-ChR2, was expressed in SHY4 cells, we found that it was also in this organism efficiently sorted to the plasma membrane”.

Our response: This criticism can be extended to any cellular system including neurons in which ChR2 and its variants are heterologously expressed (see for example: Mattis et al. (2014) Nature methods 11:763-772, Sugiyama et al. (2009) Photochem Photobiol. Sci. 8:328-336, Tomita et al. (2014) American Soc Gene Cell Therapy 22:1434-1440). Also in these systems the protein can be seen not only in the plasma membrane but also in endo-membranes. In fact, an improved sorting and targeting of ChR2 in mammalian cells is a big issue in the field of optogenetics. In addition to this general issue on ChR2 sorting it is important to remember that heterologous expression under a strong promotor will always generate some ChR2 (GFP fluorescence) in endomembranes. This originates from properly folded protein in the secretory pathway on the way to the plasma membrane or recycled protein in endosomes; also, a contribution of misfolded proteins cannot be excluded. In this respect our data are not different from results obtained with other expression systems. We now mention this in the manuscript.

Reviewer: (3) From Fig. 1 title, the authors stated that ChR2 is properly expressed in yeast. Yes, ChR2 is expressed but I disagree that it is “properly” expressed as most of ChR2 proteins not at the PM and so might not be functional.

Our response: See response to same criticism above.

Reviewer: (4) In the middle of page 10, the authors stated that the data is “not explicitly shown here”. I suggest reporting the results here or to remove this statement.

Our response: We believe, the statement provides useful information. We decided not to add the 500 and 600 mM data in Fig. 5B, since this would make Fig.5B hard to read. However, the extracted data (reduced growth rate) for 500 and 600 mM NaCl are already given in Fig. 5C. They explicitly show that increasing NaCl concentration to 500 or 600 mM gives the same result as 400 mM and does not further augment the growth inhibition. Since the relevant data are included in Fig. 5C we delete the notion “not explicitly shown here” to avoid the impression that we are not showing the data.

Reviewer: (5) The manuscript feels incomplete. The authors should consider performing a screen with their engineered yeast to demonstrate how it can be used and that it can be used successfully. Alternatively, the authors might want to consider characterizing ChR2 in yeast to show that yeast is a powerful vehicle to characterize a protein that will be difficult to study in its endogenous environment. In my opinion, the manuscript is partial without addressing this point.

Our response: The intention of the manuscript is to provide an easy test or screening system for channelrhodopsins and even beyond this for any retinal dependent protein in yeast. We are not advertising this system for a detailed characterization of the proteins of interest. Such an in-depth characterization of channelrhodopsins still requires high resolution electrical or fluorescent methods. The title of the paper therefore reads ….for functional testing… To avoid wrong expectations in our system we are now spelling out in the revised manuscript in more detail the intentions, benefits and limitations of the system.

Minor points to address

Reviewer: (1) Space missing between “Fig.” and numbers as well as between numbers and units (such as 1mM should be 1 mM) through the manuscript.

Our response: Thanks for pointing this out; we have corrected this.

Reviewer: (2) Please indicate how many biological replicates for experiments in figure legends.

Our response: We are surprised by this comment because the relevant numbers are already given in the figure legends where relevant, i.e. when statistical information is provided (Figs. 2, 4, 5 and 7)

Attachment

Submitted filename: Reviewer.pdf

Decision Letter 1

Patrick Lajoie

21 Mar 2023

PONE-D-22-35053R1Tailoring baker’s yeast Saccharomyces cerevisiae for functional testing of ChannelrhodopsinPLOS ONE

Dear Dr. Thiel,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

As you can see below, one review as a couple points that should be addressed before publication. I believe these can be easily addressed in a revised version of the manuscript. 

Please submit your revised manuscript by May 05 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Patrick Lajoie, PhD

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: (No Response)

Reviewer #2: In this manuscript, the authors report an engineered and validated Saccharomyces cerevisiae strain that expressed the light-activated Channelrhodopsin 2 (ChR2) that could be used for future screens.

Overall, the authors addressed most of my concerned except the few points below that still need to be addressed.

(1) I understand the author response to my original comment (2). However, I am still unconvinced with the author explanation mostly because I am unable to confidently assess the localizations of N/K-ChR2-eYFP with the microscopy images shown in Fig. 5A. For most the cells, the protein seems to be localized internally but it can’t be determined in which organelle it is localized. Ideally, they should show the co-localization of N/K-ChR2-eYFP with organelle markers. Again, I have the impression that N/K-ChR2-eYFP is mostly internalized with a small proportion localized at the PM.

(2) Please indicate how many biological replicates for experiments in figure legends. The authors responded that “We are surprised by this comment because the relevant numbers are already given in the figure legends where relevant, i.e. when statistical information is provided (Figs. 2, 4, 5 and 7)”. I am sorry for the confusions, but I mean that it is not indicated in the method nor in figure legends if the other experiments were repeated at least in triplicates such as Fig. 1A, 1B, 1C, 1D, 2B (three values means three independent biological replicates?), 3A, 3B, 3C, 4C, 4D, 5A, and 6. Alternatively, the authors can state in the method section that all experiments have been conduced at least for three independent biological replicates if it is the case.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2023 Apr 13;18(4):e0280711. doi: 10.1371/journal.pone.0280711.r004

Author response to Decision Letter 1


27 Mar 2023

Dear reviewer, thanks for pointing out issues that might have been not clear yet in the previous version of the manuscript. We have now amended the manuscript accordingly:

Reviewer:

I understand the author response to my original comment (2). However, I am still unconvinced with the author explanation mostly because I am unable to confidently assess the localizations of N/K-ChR2-eYFP with the microscopy images shown in Fig. 5A. For most the cells, the protein seems to be localized internally but it can’t be determined in which organelle it is localized. Ideally, they should show the co-localization of N/K-ChR2-eYFP with organelle markers. Again, I have the impression that N/K-ChR2-eYFP is mostly internalized with a small proportion localized at the PM.

Our response:

We do not question fluorescence in internal membranes, but GFP tagged channel protein is for sure visible in the plasma membrane of all cells, which express the channel protein. This occurs on a variable background ranging from no fluorescence signal inside the cell (cell now indicated in Fig. 5) to an intense labeling of internal structures. By adding two additional paragraphs we want to make the important point that already the presence of GFP fluorescence in the plasma membrane is sufficient for using the yeast system for complementation assays. This is irrespective of the presence/absence of cytosolic signals.

To strengthen our message, we have:

a. added a quantitative analysis on fluorescence localization in the plasma membrane versus the cell interior. This analysis confirms the general presence of GFP fluorescence in the plasma membrane not only in a few images but in a large cohort of analyzed cells (page 5).

b. We have added an experiment (page 3, Fig. S1) in which we confirm, with the help of a positive control, that a weak GFP signal from a channel protein in the plasma membrane is sufficient for using the K+ uptake deficient yeast strain for complementation assays. Such a complementation can only be interpreted in the context of channel activity in the plasma membrane.

c. We have not performed colocalization assays since for our application it is not relevant to identify the cytosolic localization of the protein. From the biogenesis of a membrane proteins, we know that we will find positive colocalization with the Golgi and the ER. Although this information is interesting in the context of channel synthesis and sorting it will not provide crucial insights into the positive or negative outcome of our complementation assays.

Reviewer:

Please indicate how many biological replicates for experiments in figure legends. The authors responded that “We are surprised by this comment because the relevant numbers are already given in the figure legends where relevant, i.e. when statistical information is provided (Figs. 2, 4, 5 and 7)”. I am sorry for the confusions, but I mean that it is not indicated in the method nor in figure legends if the other experiments were repeated at least in triplicates such as Fig. 1A, 1B, 1C, 1D, 2B (three values means three independent biological replicates?), 3A, 3B, 3C, 4C, 4D, 5A, and 6. Alternatively, the authors can state in the method section that all experiments have been conduced at least for three independent biological replicates if it is the case.

Our response:

We included an extra chapter on “statistics” in the material and method section in which we state all the information on experimental replicates etc.

Attachment

Submitted filename: Dear reviewer.docx

Decision Letter 2

Patrick Lajoie

28 Mar 2023

Tailoring baker’s yeast Saccharomyces cerevisiae for functional testing of Channelrhodopsin

PONE-D-22-35053R2

Dear Dr. Thiel,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Patrick Lajoie, PhD

Academic Editor

PLOS ONE

Acceptance letter

Patrick Lajoie

4 Apr 2023

PONE-D-22-35053R2

Tailoring baker’s yeast Saccharomyces cerevisiae for functional testing of Channelrhodopsin

Dear Dr. Thiel:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Patrick Lajoie

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Fig. Functional complementation of SHY4 cells by K+ channel.

    (A) Fluorescence images of SHY4 cells transiently expressing GFP tagged K+ channel KcvPBCV1 (KcvPBCV1::GFP). Scale bar = 5 μm. (B) Serial dilutions of K+ uptake deficient SHY4 cells transformed with KcvPBCV1::GFP plasmid or the corresponding empty vector (ev). Cells spotted on SD-ura plates with either high (100 mM KCl, top) or without K+ supplementation and incubated for 72h. KcvPBCV1 rescues growth of SHY4 cells on SD-ura medium without additional K+ (bottom row). For experimental details see [1]. [1] Gebhardt M, Hoffgaard F, Hamacher K, Kast SM, Moroni A, Thiel G. Membrane anchoring and interaction between transmembrane domains is crucial for K+ channel function. J. Biol. Chem. 2011; 286:11299–11306.

    (PDF)

    S2 Fig. N/K-ChR2-eYFP expression does not restore growth of SHY4 cells on low K+ agar medium.

    Serial dilutions of all-trans retinal producing K+ uptake deficient SHY4 cells transformed with either a plasmid for constitutive expression of N/K-ChR2-eYFP or the corresponding empty vector (ev). Cells spotted on SD-ura plates with either high (100 mM KCl, top) or a without K+ supplementation and incubated for 72h. Colonies grow only on SD-ura medium with high K+ concentration independently of incubation in the dark (left) or in blue light (right).

    (PDF)

    S1 Data

    (XLSX)

    Attachment

    Submitted filename: Reviewer.pdf

    Attachment

    Submitted filename: Dear reviewer.docx

    Data Availability Statement

    All relevant data are within the paper and its Supporting information files.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES